Fundraising Fox

Treo Ventures, Llc2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

NuXcelnuxcel.comOct 2024 · $66M✓ verified

NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.

Deep TechHealthtechMedical Devices

Co-investorsAmzak HealthAPERTURE Venture PartnersNorwest Venture PartnersOSF VenturesU.S. Venture Partners

Hyalexhyalex.comin𝕏Oct 2024

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Executive Officer, Director)Mira Sahney(Executive Officer, Director)David Myung(Director)

BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in

Board seatBrad H. Vale· per SEC Form D

Co-investorsCanaan PartnersOUP (Osage University Partners)

ShiraTronicsshiratronics.cominSep 2024 · $66M

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.

BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US

Robert Binney(Executive Officer, Director)

BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)

Board seatBrad H. ValeMudit Jain· per SEC Form D

Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more

Iveacareiveacare.comApr 2024 · $27.5M

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.

Deep TechHealthtechMedical DevicesRoseville, US

Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)

BoardKirk Nielsen(Director)in

Co-investorsHatteras Venture PartnersVensana Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.